Aerts J M, Donker-Koopman W E, Koot M, Barranger J A, Tager J M, Schram A W
Clin Chim Acta. 1986 Jul 30;158(2):155-63. doi: 10.1016/0009-8981(86)90231-7.
Glucocerebrosidase is present in considerable amounts in human urine. The enzyme is stable in concentrated urine for several days when stored at 0 degrees C. Like tissue glucocerebrosidase, the urinary enzyme is inhibited by conduritol B-epoxide and hydrolyses not only glucocerebroside but also the synthetic substrate 4-methyl-umbelliferyl-beta-D-glucoside. The enzyme is deficient in urine from patients with Gaucher disease (type 1). It is possible to discriminate completely between patients with type 1 Gaucher disease and control subjects by measuring the ratio glucocerebrosidase/beta-hexosaminidase in urine. The value of this ratio (mean +/- SE) with the synthetic substrates 4-methylumbelliferyl-beta-glucoside and p-nitrophenyl-beta-N-acetylglucosaminide, respectively, was 34.2 +/- 3.7 (n = 24) in the controls and 2.1 +/- 0.9 (n = 21) in the patients.
葡萄糖脑苷脂酶在人类尿液中大量存在。该酶在0摄氏度储存时,在浓缩尿液中可稳定存在数天。与组织中的葡萄糖脑苷脂酶一样,尿酶受制霉菌醇B - 环氧化物抑制,不仅能水解葡萄糖脑苷脂,还能水解合成底物4 - 甲基伞形酮基 - β - D - 葡萄糖苷。戈谢病(1型)患者的尿液中该酶缺乏。通过测量尿液中葡萄糖脑苷脂酶/β - 己糖胺酶的比值,能够完全区分1型戈谢病患者和对照者。分别以合成底物4 - 甲基伞形酮基 - β - 葡萄糖苷和对硝基苯基 - β - N - 乙酰氨基葡萄糖苷计算,对照者的该比值(平均值±标准误)为34.2±3.7(n = 24),患者为2.1±0.9(n = 21)。